Abstract
The authors have been involved with initial concept development and implementation of the outsourcing management process at their respective companies. Representing three large global pharmaceutical companies and one large biotechnology company, they will discuss outsourcing management at their companies, how it developed, and where it seems to be headed on the road to virtual drug development.
Keywords
Get full access to this article
View all access options for this article.
References
1.
Browning
ES
. Change in Health Care Shakes Up the Business of Drug Development . The Wall Street Journal. March 28, 1995 .
2.
Whittaker
R
. Grants Market to Grow by More Than $250 Million In 1996 . CenterWatch. February 1, 1996 ;3 (2 ).
3.
Kaplan
RS
Norton
DP
. Putting the Balanced Score-cord to Work . Harvard Bus Rev.
1993 ; September-October: 134 –147 .
4.Pharmaceutical Outsourcing Management Association (POMA), established January 1995. For more information contact authors.
5.
Speh
C
. Specialty Providers Carve Out A Niche . CenterWatch. April 1, 1996 ;3 (2 ).
6.
Whittaker
R
. The Booming CROs . CenterWatch. April 1, 1996 ;3 (2 ).
7.
Watanabe
ME
. Research-For-Hire Companies Proliferate . The Scientist. December 11, 1995 ;9 (24 ) 1 , 4 –5 .
8.
Hedrick
T
Elleam
L
. Strategic Supplier Partnering: An International Study . Center for Advanced Purchasing Studies . Arizona State University . 1993 .
9.
Jerrems
CL
. Managing Clinical Grant Overhead Costs at Merck . App Clin Trials. June 1995 ;4 (6 ).
10.
Browning
ES
. Many Drug Makers Curb Research . The Wall Street Journal. March 28, 1995 .